These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24164687)

  • 21. [The role of respiratory infection in exacerbation of chronic obstructive pulmonary disease].
    Dacydchenko SV; Bova AA
    Klin Med (Mosk); 2007; 85(5):10-5. PubMed ID: 17665597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Expression of IL-6, TNF-
    Zheng J; Shi Y; Xiong L; Zhang W; Li Y; Gibson PG; Simpson JL; Zhang C; Lu J; Sai J; Wang G; Wang F
    J Immunol Res; 2017; 2017():8539294. PubMed ID: 28352642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort.
    Langsetmo L; Platt RW; Ernst P; Bourbeau J
    Am J Respir Crit Care Med; 2008 Feb; 177(4):396-401. PubMed ID: 18048806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COPD exacerbations: causes, prevention, and treatment.
    Mackay AJ; Hurst JR
    Immunol Allergy Clin North Am; 2013 Feb; 33(1):95-115. PubMed ID: 23337067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations.
    Xu W; Collet JP; Shapiro S; Lin Y; Yang T; Platt RW; Wang C; Bourbeau J
    Am J Respir Crit Care Med; 2008 Nov; 178(9):913-20. PubMed ID: 18755925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study on the relationship between airway bacterial infections and acute exacerbations in patients with chronic obstructive pulmonary disease].
    Zhou YQ; Xie CM; Chen DM; Chen L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 May; 28(5):503-6. PubMed ID: 17877185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary bacterial coinfection in infants and children with viral respiratory infection.
    Thorburn K; Riordan A
    Expert Rev Anti Infect Ther; 2012 Aug; 10(8):909-16. PubMed ID: 23030330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Exacerbations of chronic obstructive pulmonary disease].
    Olivieri D; Calabrò E; Marangio E
    Ann Ist Super Sanita; 2003; 39(4):549-55. PubMed ID: 15098575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease.
    Bozinovski S; Hutchinson A; Thompson M; Macgregor L; Black J; Giannakis E; Karlsson AS; Silvestrini R; Smallwood D; Vlahos R; Irving LB; Anderson GP
    Am J Respir Crit Care Med; 2008 Feb; 177(3):269-78. PubMed ID: 18006888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statistical analysis of chronic obstructive pulmonary disease exacerbations in clinical studies: expectations and limitations.
    Gillissen A; Glaab T; Lewis M; Buhl R; Worth H
    J Physiol Pharmacol; 2009 Nov; 60 Suppl 5():7-11. PubMed ID: 20134031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammation and infection in exacerbations of chronic obstructive pulmonary disease.
    Pietila MP; Thomas CF
    Semin Respir Infect; 2003 Mar; 18(1):9-16. PubMed ID: 12652449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical determinants of exacerbations in severe, early-onset COPD.
    Foreman MG; DeMeo DL; Hersh CP; Reilly JJ; Silverman EK
    Eur Respir J; 2007 Dec; 30(6):1124-30. PubMed ID: 17715170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosing viral and bacterial respiratory infections in acute COPD exacerbations by an electronic nose: a pilot study.
    van Geffen WH; Bruins M; Kerstjens HA
    J Breath Res; 2016 Jun; 10(3):036001. PubMed ID: 27310311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The impact of comorbidities on the length of hospital treatment in patients with chronic obstructive pulmonary disease].
    Nowiński A; Kamiński D; Korzybski D; Stokłosa A; Górecka D
    Pneumonol Alergol Pol; 2011; 79(6):388-96. PubMed ID: 22028117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How should we define and classify exacerbations in chronic obstructive pulmonary disease?
    Trigueros Carrero JA
    Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):33-41. PubMed ID: 23551022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of comorbid diabetes on length of stay and risk of death in patients admitted with acute exacerbations of COPD.
    Parappil A; Depczynski B; Collett P; Marks GB
    Respirology; 2010 Aug; 15(6):918-22. PubMed ID: 20546185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nutritional state during COPD exacerbation: clinical and prognostic implications.
    Girón R; Matesanz C; García-Río F; de Santiago E; Mancha A; Rodríguez-Salvanés F; Ancochea J
    Ann Nutr Metab; 2009; 54(1):52-8. PubMed ID: 19252400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease.
    Kiser TH; Allen RR; Valuck RJ; Moss M; Vandivier RW
    Am J Respir Crit Care Med; 2014 May; 189(9):1052-64. PubMed ID: 24617842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of atypical respiratory pathogens in exacerbations of chronic obstructive pulmonary disease.
    Diederen BM; van der Valk PD; Kluytmans JA; Peeters MF; Hendrix R
    Eur Respir J; 2007 Aug; 30(2):240-4. PubMed ID: 17459899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of pneumonia on hospitalizations due to acute exacerbations of COPD.
    Andreassen SL; Liaaen ED; Stenfors N; Henriksen AH
    Clin Respir J; 2014 Jan; 8(1):93-9. PubMed ID: 23889911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.